TCR-dependent sensitization of human γδ T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance

OncoImmunology

Volumn 4, Issue 5, 2015, Pages

  Guerville, Florent ^a,b,c   Daburon, Sophie ^a,b   Marlin, Romain ^a,b   Lartigue, Lydia ^d   Loizon, Severine ^a,b   Pitard, Vincent ^a,b   Couzi, Lionel ^a,b,c   Moreau, Jean François ^a,b,c   Déchanetmerville, Julie ^a,b   Faustin, Benjamin ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS Bordeaux Segalen University   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d INSTITUT BERGONIÉ   (France)

Author keywords

Cancer; Caspase 1; Cytomegalovirus; IL 18; Immunology; Inflammasome; TCR; T cells

Indexed keywords

CASPASE INHIBITOR; GAMMA INTERFERON; INFLAMMASOME; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR BETA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; RECOMBINANT INTERLEUKIN 18; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANALYTIC METHOD; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; CYTOTOXICITY; DEGRANULATION ASSAY; DISEASE SURVEILLANCE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; GLIOBLASTOMA; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; INNATE IMMUNITY; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; NEOPLASM; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 85053361522     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2014.1003011     Document Type: Article

References (50)

1. Chien Y, Meyer C, Bonneville M. γδ T cells: first line of defense and beyond. Annu Rev Immunol 2014; 32:121-55; PMID:24387714; http://dx.doi.org/10.1146/annurevimmunol-032713-120216
2. Vantourout P, Hayday A. Six-of-the-best: unique contributions of γδ T cells to immunology. Nat Rev Immunol 2013; 13:88-100; PMID:23348415; http:// dx.doi.org/10.1038/nri3384
3. GirardiM,OppenheimDE, Steele CR, Lewis JM, Glusac E, Filler R, Hobby P, Sutton B, Tigelaar RE, Hayday AC. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294:605-9; PMID:11567106; http:// dx.doi.org/10.1126/science.1063916
4. Born W, Cady C, Jones-Carson J, Mukasa A, Lahn M, O'Brien R. Immunoregulatory functions of gamma delta T cells. Adv Immunol 1999; 71:77-144; PMID:9917911; http://dx.doi.org/10.1016/S0065-2776(08)60400-9
5. Ma Y, Aymeric L, Locher C,Mattarollo SR,DelahayeNF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F, Casares N, et al. Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J ExpMed 2011; 208:491-503; PMID:21383056; http://dx.doi.org/ 10.1084/jem.20100269
6. Wilhelm M, Kunzmann V, Eckstein S, Reimer P, Weissinger F, Ruediger T, Tony HP. Gammadelta T cells for immune therapy of patients with lymphoid malignancies. Blood 2003; 102:200-6; PMID:12623838; http://dx. doi.org/10.1182/blood-2002-12-3665
7. Lafarge X, Merville P, Cazin MC, Bergé F, Potaux L, Moreau JF, Déchanet-Merville J. Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role. J Infect Dis 2001; 184:533-41; PMID:11494158; http://dx.doi.org/10.1086/322843
8. Peng G, Wang HY, Peng W, Kiniwa Y, Seo KH, Wang RF. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway. Immunity 2007; 27:334-48; PMID:17656116; http://dx. doi.org/10.1016/j.immuni.2007.05.020
9. Brandes M, Willimann K, Moser B. Professional antigen-presentation function by human gammadelta T cells. Science 2005; 309:264-8; PMID:15933162; http://dx.doi.org/10.1126/science.1110267
10. Toulon A, Breton L, Taylor KR, Tenenhaus M, Bhavsar D, Lanigan C, Rudolph R, Jameson J, Havran WL. A role for human skin-resident T cells in wound healing. J Exp Med 2009; 206:743-50; PMID:19307328; http://dx.doi.org/10.1084/jem.20081787
11. Fisher JP, Heuijerjans J, Yan M, Gustafsson K, Anderson J. γδ T cells for cancer immunotherapy: a systematic review of clinical trials. Oncoimmunology 2014; 3: e27572; PMID:24734216; http://dx.doi.org/10.4161/ onci.27572
12. Siegers GM, Lamb LS. Cytotoxic and regulatory properties of circulating Vδ1C γδ T cells: a new player on the cell therapy field? Mol Ther J Am Soc Gene Ther 2014; 22:1416-22; http://dx.doi.org/10.1038/mt.2014.104
13. Déchanet J, Merville P, Lim A, Retière C, Pitard V, Lafarge X, Michelson S, Méric C, Hallet MM, Kourilsky P, et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 1999; 103:1437-49; http://dx.doi.org/10.1172/ JCI5409
14. Pitard V, Roumanes D, Lafarge X, Couzi L, Garrigue I, Lafon ME, Merville P, Moreau JF, Déchanet-Merville J. Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection. Blood 2008; 112:1317-24; PMID:18539896; http://dx.doi.org/10.1182/blood-2008-01-136713
15. Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, Kühr J, Mascart F, Schmitt-Graeff A, Niemeyer C, Fisch P. A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest 2005; 115:3140-8; PMID:16211094; http://dx.doi.org/10.1172/JCI25221
16. Knight A, Madrigal AJ, Grace S, Sivakumaran J, Kottaridis P, Mackinnon S, Travers PJ, Lowdell MW. The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood 2010; 116:2164-72; PMID:20576814; http://dx. doi.org/10.1182/blood-2010-01-255166
17. Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, Van Rysselberge M, Twité N, Goldman M, Marchant A, Willems F. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med 2010; 207:807-21; PMID:20368575; http://dx. doi.org/10.1084/jem.20090348
18. Willcox CR, Pitard V, Netzer S, Couzi L, Salim M, Silberzahn T, Moreau JF, Hayday AC, Willcox BE, Déchanet-Merville J. Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor. Nat Immunol 2012; 13:872-9; PMID:22885985; http://dx.doi. org/10.1038/ni.2394
19. Couzi L, Levaillant Y, Jamai A, Pitard V, Lassalle R, Martin K, Garrigue I, Hawchar O, Siberchicot F, Moore N, et al. Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation. J Am Soc Nephrol 2010; 21:181-8; PMID:19713314; http://dx.doi.org/10.1681/ASN.2008101072
20. Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell 2014; 157:1013-22; PMID:24855941; http://dx.doi.org/10.1016/j. cell.2014.04.007
21. Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell 2002; 10:417-26; PMID:12191486; http://dx.doi.org/ 10.1016/S1097-2765(02)00599-3
22. De Nardo D, Latz E. NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol 2011; 32:373-9; PMID:21733753; http://dx.doi.org/ 10.1016/j.it.2011.05.004
23. Henao-Mejia J, Elinav E, Thaiss CA, Flavell RA. Inflammasomes and metabolic disease. Annu Rev Physiol 2014; 76:57-78; PMID:24274736; http://dx.doi. org/10.1146/annurev-physiol-021113-170324
24. Lartigue L, Faustin B. Mitochondria: metabolic regulators of innate immune responses to pathogens and cell stress. Int J Biochem Cell Biol 2013; 45:2052-6; PMID:23838171; http://dx.doi.org/10.1016/j.biocel. 2013.06.014
25. Schulze A, Harris AL. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 2012; 491:364-73; PMID:23151579; http://dx.doi. org/10.1038/nature11706
26. Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat Biotechnol 2008; 26:1179-86; PMID:18820684; http://dx.doi.org/ 10.1038/nbt.1500
27. Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KSB, McIntire CR, LeBlanc PM, Meunier C, Turbide C, Gros P, Beauchemin N, et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 2010; 32:367-78; PMID:20226691; http://dx.doi.org/ 10.1016/j.immuni.2010.02.012
28. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011; 145:745-57; PMID:21565393; http://dx.doi. org/10.1016/j.cell.2011.04.022
29. Doyle SL, CampbellM, Ozaki E, Salomon RG, Mori A, Kenna PF, Farrar GJ, Kiang A-S, Humphries MM, Lavelle EC, et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components. Nat Med 2012; 18:791-8; PMID:22484808; http://dx.doi.org/10.1038/nm.2717
30. Lebel-Binay S, Thiounn N, De Pinieux G, Vieillefond A, Debré B, Bonnefoy J-Y, Fridman W-H, Pagès F. IL-18 is produced by prostate cancer cells and secreted in response to interferons. Int J Cancer 2003; 106:827-35; PMID:12918059; http://dx.doi.org/10.1002/ijc.11285
31. Vidal-Vanaclocha F, Mendoza L, Telleria N, Salado C, Valcárcel M, Gallot N, Carrascal T, Egilegor E, Beaskoetxea J, Dinarello CA. Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression. Cancer Metastasis Rev 2006; 25:417-34; PMID:17001512; http://dx.doi.org/ 10.1007/s10555-006-9013-3
32. Terme M, Ullrich E, Aymeric L, Meinhardt K, Coudert JD, Desbois M, Ghiringhelli F, Viaud S, Ryffel B, Yagita H, et al. Cancer-induced immunosuppression: IL-18-elicited immunoablative NK cells. Cancer Res 2012; 72:2757-67; PMID:22427351; http://dx.doi. org/10.1158/0008-5472.CAN-11-3379
33. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, van Bruggen R, Tschopp J. Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J Histochem Cytochem 2007; 55:443-52; PMID:17164409; http://dx.doi.org/10.1369/jhc. 6A7101.2006
34. Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Philbrick WM, et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 2014; 156:1045-59; PMID:24581500; http://dx.doi.org/10.1016/j.cell. 2014.01.026
35. Halary F, Pitard V, Dlubek D, Krzysiek R, de la Salle H, Merville P, Dromer C, Emilie D, Moreau JF, Déchanet-Merville J. Shared reactivity of V{delta}2 (neg) {gamma}{delta} T cells against cytomegalovirusinfected cells and tumor intestinal epithelial cells. J Exp Med 2005; 201:1567-78; PMID:15897274; http://dx. doi.org/10.1084/jem.20041851
36. Yang JH, Zhu HTL, Murphy TLW, Ouyang W, Murphy KM. IL-18-stimulated GADD45 β required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol 2001; 2:157-64; PMID:11175814; http://dx.doi.org/10.1038/84264
37. Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front. Immunol 2013; 4:289.
38. Scheper W, van Dorp S, Kersting S, Pietersma F, Lindemans C, Hol S, Heijhuurs S, Sebestyen Z, Gründer C, Marcu-Malina V, et al. γδT cells elicited by CMV reactivation after allo-SCT cross-recognizeCMV and leukemia. Leukemia 2013; 27:1328-38; PMID:23277330; http:// dx.doi.org/10.1038/leu.2012.374
39. Witherden DA, Verdino P, Rieder SE, Garijo O, Mills RE, Teyton L, Fischer WH, Wilson IA, Havran WL. The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science 2010; 329:1205-10; PMID:20813954; http://dx.doi.org/10.1126/science.1192698
40. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KHG. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009; 31:331-41; PMID:19682929; http://dx. doi.org/10.1016/j.immuni.2009.08.001
41. Rathinam VAK, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010; 11:395-402; PMID:20351692; http://dx.doi.org/10.1038/ni.1864
42. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes in health and disease. Nature 2012; 481:278-86; PMID:22258606; http://dx.doi.org/10.1038/ nature10759
43. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15:1170-8; PMID:19767732; http://dx.doi.org/ 10.1038/nm.2028
44. Tsutsui H,Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, Higashino K, Nakanishi K. IL-18 accounts for both TNF-α-and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol 1997; 159:3961-7.
45. Hyodo Y, Matsui K, Hayashi N, Tsutsui H, Kashiwamura S, Yamauchi H, Hiroishi K, Takeda K, Tagawa Y, Iwakura Y, et al. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor. J Immunol 1999; 162:1662-8; PMID:9973427
46. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161:3400-7; PMID:9759857
47. Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol 2000; 30:1113-9; PMID:10760800; http://dx.doi.org/10.1002/(SICI)1521-4141(200004) 30:4%3c1113::AID-IMMU1113%3e3.0.CO;2-P
48. Nakahira M, Tomura M, Iwasaki M, Ahn HJ, Bian Y, Hamaoka T, Ohta T, Kurimoto M, Fujiwara H. An absolute requirement for STAT4 and a role for IFNgamma as an amplifying factor in IL-12 induction of the functional IL-18 receptor complex. J Immunol 2001; 167:1306-12; PMID:11466347; http://dx.doi. org/10.4049/jimmunol.167.3.1306
49. Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, Satterthwait AC, Reed JC. Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 2003; 423:456-461; PMID:12732850; http://dx.doi. org/10.1038/nature01627
50. Faustin B, Lartigue L, Bruey J-M, Luciano F, Sergienko E, Bailly-Maitre B, Volkmann N, Hanein D, Rouiller I, Reed JC. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 2007; 25:713-24; PMID:17349957; http:// dx.doi.org/10.1016/j.molcel.2007.01.032